Skip to content
Search

Latest Stories

England sees net loss of 101 pharmacies in 2023, FOI request reveals

In its response to a Freedom of Information Request (FOI), the NHS Business Services Authority (NHSBSA) has confirmed a net decrease of 101 pharmacies in England — with 371 closures and 270 new contracts for the year ending March 31, 2023, compared to the preceding year. Meanwhile, the General Pharmaceutical Council data projected a drop of 43 registered pharmacies in England, Wales, and Scotland during the same period.

The data, released by business advisor Christie & Co in its annual pharmacy market review on Sept. 5, revealed a total of 14,328 pharmacies across all four UK country regions as of March 31, 2023, indicating a 0.3 per cent decrease from the previous year. Corporate operators experienced a net reduction of 249 pharmacies, while the total number of independent operators remained consistent with 2022.


According to the study, the corporate sector saw the most substantial shift, with a 13.7 per cent reduction in businesses operating 300 or more pharmacies. Following closely, groups managing 11 to 15 pharmacies experienced a 5.6 per cent decrease. Christie & Co attributed this shift in group size to operators acquiring additional pharmacies through corporate disposal opportunities throughout the year.

The report noted that on a contract-type basis, it's worth acknowledging that only England has 100-hour and distance selling contracts among the 11,779 registered pharmacies. Additionally, the report emphasised that the sector is primarily dominated by regional multiples, with companies managing over 300 pharmacies constituting only about 34 per cent of the overall market.

Rising wages spark employment worries

Recent reports from the Office for National Statistics indicated a record 7.8 per cent annual wage growth in the UK up to June 2023. This surge has compounded employment challenges, establishing it as one of the most pressing cost issues in the sector, Christie & Co said in its study.

The report highlighted that pharmacists and qualified staff are increasingly attracted to roles in GP surgeries and PCNs due to the ongoing Additional Roles Reimbursement Scheme. Referring to data released in NHS England’s May 2023 Primary Care Workforce Quarterly Update, the report noted that 6,331 FTE pharmacists and 2,124 pharmacy technicians have embraced roles under this scheme.

While this aids the government's commitment to enlist 26,000 new staff in general practice by 2024, it offers no relief to the ongoing employment crisis faced by the pharmacy sector, the report noted.

Surge in locum demand

Although some contractors discussed a brief alleviation in locum costs in the first half of 2023, workforce demands persistently propel locum rate hikes in three of the four UK country regions. Notably, only Scotland saw a reduction, with average rates declining from £48.86 in July 2022 to £45.36 in July 2023, the study said.

According to data from Locate a Locum, average locum rates in England, Wales, and Northern Ireland increased to £37.14, £42.60, and £28.66 respectively. Analysis of 160,000 pharmacy shifts between June 2022 and July of this year, conducted by Locate a Locum, revealed an average hourly rate of £38.44 for a locum pharmacist in the UK.

Looking at UK towns and cities, this data sample indicates an average increase of 3.5 per cent in locum rates overall. However, there are notable variations. Inverness saw the most significant drop, averaging at 14.8 per cent, while Cardiff experienced the highest increase at an average of 30.3 per cent.

"Regional variations highlight market complexities, local challenges, and widespread NHS pressures," said Jonathon Clarke, CEO of Locate a Locum. "Community pharmacies grapple with heightened dispensing demands while steadfastly supporting NHS services. This occurs amidst a backdrop of reduced funding, drug shortages, and store closures. Market dynamics are leaning more heavily on locums to sustain operational continuity. Notably, we've seen an uptick in negotiations between pharmacies and locum pharmacists, aiming to enhance shift fill rates and subsequently decrease the necessity for emergency cover."

Meanwhile, the Royal Pharmaceutical Society and Pharmacist Support charity have underscored the vital importance of safeguarding pharmacy teams from burnout to ensure uninterrupted patient safety. Their report, 'Pharmacy Workforce Wellbeing', published on October 4, emerged from a May 2023 roundtable event with representatives from various sectors. It highlighted the pressing need for strategic solutions, addressing rising workloads and limited capacity in community pharmacies. The report suggested optimising skill mix and incorporating advanced technologies as avenues for capacity enhancement.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less